Squamous Cell Carcinoma of the Anal Canal

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS guidance · 2026-01-08
Clinical Trial Update: An Early Access Program Guideline to Provide Access to Retifanlimab (INCMGA00012) Together With Carboplatin and Paclitaxel for Squamous Carcinoma of the Anal Canal (SCAC)
This document describes an Early Access Program Guideline to provide access to retifanlimab (INCMGA00012) with carboplatin and paclitaxel fo…